Literature DB >> 8302944

Metabolism of caffeic acid in the isolated perfused rat liver.

H G Gumbinger1, U Vahlensieck, H Winterhoff.   

Abstract

Caffeic acid as well as its oxidation products exert a spectrum of biological effects in in vitro testing. To get an idea of the amount as well as the mode of biotransformation, caffeic acid metabolism was investigated by means of the isolated perfused rat liver. The first-pass effect was not pronounced: 93.3% of caffeic acid dose appeared unchanged after one liver passage. Products of caffeic acid oxidation (cyclolignan derivatives) as well as ferulic and isoferulic acid as methylation products were found in the perfusion medium. In addition, a cyclization product, esculetin, was observed. In the bile, mainly glucuronides as well as sulfates of caffeic acid could be determined. Thus, oxidation products and other metabolites formed by liver metabolism can be responsible for the biological effects in vivo.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8302944     DOI: 10.1055/s-2006-959745

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  3 in total

1.  Biotransformation of aesculin by human gut bacteria and identification of its metabolites in rat urine.

Authors:  Wei-Jun Ding; Yun Deng; Hao Feng; Wei-Wei Liu; Rong Hu; Xiang Li; Zhe-Ming Gu; Xiao-Ping Dong
Journal:  World J Gastroenterol       Date:  2009-03-28       Impact factor: 5.742

2.  Comparative study on the inhibitory effect of caffeic and chlorogenic acids on key enzymes linked to Alzheimer's disease and some pro-oxidant induced oxidative stress in rats' brain-in vitro.

Authors:  Ganiyu Oboh; Odunayo M Agunloye; Ayodele J Akinyemi; Adedayo O Ademiluyi; Stephen A Adefegha
Journal:  Neurochem Res       Date:  2012-11-27       Impact factor: 3.996

3.  Urinary excretion rate and bioavailability of chlorogenic acid, caffeic acid, p-coumaric acid, and ferulic acid in non-fasted rats maintained under physiological conditions.

Authors:  Kunihiro Kishida; Harumi Matsumoto
Journal:  Heliyon       Date:  2019-11-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.